Radiopharm Theranostics Ltd
For the period ended Oct 27, 2026. Filed Oct 27, 2026.
View on SEC.govAbout this filing
What a company based outside the US has published at home or sent to its shareholders. It is how many foreign companies share results and news between annual reports.
Oct 27, 2026 · Filed Oct 27, 2026
Use the contents to explore the available documents and sections.
Contents
EXPLANATORY NOTE
Radiopharm Theranostics Limited (the “Company”) published one announcement (the “Public Notice”) to the Australian Securities Exchange on October 27, 2026 titled:
“Notice of Annual General Meeting/Proxy Form”
A copy of the Public Notice is attached as an exhibit to this report on Form 6-K.
This report on Form 6-K (including any exhibit hereto) shall not be deemed to be “filed” for purposes of the Securities Exchange Act of 1934 and shall not be incorporated by reference into any registration statement or prospectus under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such registration statement or prospectus.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.